Intraocular Tumor Antigen Drains Specifically to Submandibular Lymph Nodes, Resulting in an Abortive Cytotoxic T Cell Reaction

Journal of Immunology

Volumn 172, Issue 3, 2004, Pages 1567-1574

  Boonman, Zita F H M ^a   Van Mierlo, Geertje J D ^a   Fransen, Marieke F ^a   Franken, Kees L M C ^a   Offringa, Rienk ^a   Melief, Cornelis J M ^a   Jager, Martine J ^a   Toes, René E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYO; IMMUNE RESPONSE; INTRAOCULAR TUMOR; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SUBMANDIBULAR LYMPH NODE; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; TUMOR IMMUNITY;

EID: 1642485155     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.3.1567     Document Type: Article

References (50)

1. Medawar, P. 1948. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29:58.
2. Wilbanks, G. A., and J. W. Streilein. 1991. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J. Immunol. 146:2610.
3. Wilbanks, G. A., M. Mammolenti, and J. W. Streilein. 1991. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J. Immunol. 146:3018.
4. Wilbanks, G. A., and J. W. Streilein. 1990. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen: evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 71:383.
5. Stein-Streilein, J., K. H. Sonoda, D. Faunce, and J. Zhang-Hoover. 2000. Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages. J. Leukocyte Biol. 67:488.
6. Wilbanks, G. A., and J. W. Streilein. 1992. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg. Immunol. 4:130.
7. Wilbanks, G. A., and J. W. Streilein. 1992. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β. Eur. J. Immunol. 22:1031.
8. D'Orazio, T. J., B. M. DeMarco, E. S. Mayhew, and J. Y. Niederkom. 1999. Effect of aqueous humor on apoptosis of inflammatory cell types. Invest. Ophthalmol. Visual Sci. 40:1418.
9. D'Orazio, T. J., and J. Y. Niederkom. 1998. A novel role for TGF-β and IL-10 in the induction of immune privilege. J. Immunol. 160:2089.
10. Derevjanik, N. L., S. A. Vinores, W. H. Xiao, K. Mori, T. Turon, T. Hudish, S. Dong, and P. A. Campochiaro. 2002. Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest. Ophthalmol. Visual Sci. 43:2462.
11. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189.
12. Sano, Y., and C. Sotozono. 2002. Role of Fas ligand in ocular tissue. Cornea 21:S30.
13. Clarijs, R., L. Schalkwijk, D. J. Ruiter, and R. M. de Waal. 2001. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. Invest. Ophthalmol. Visual Sci. 42:1422.
14. Sherman, S. H., K. Green, and A. M. Laties. 1978. The fate of anterior chamber fluorescein in the monkey eye. I. The anterior chamber outflow pathways. Exp. Eye Res. 27:159.
15. Green, K., S. H. Sherman, A. M. Laties, J. E. Pederson, D. E. Gaasterland, and H. M. MacLellan. 1977. Fate of anterior chamber tracers in the living rhesus monkey eye with evidence for uveo-vortex outflow. Trans. Ophthalmol. Soc. UK 97:731.
16. Bradbury, M. W., and D. F. Cole. 1980. The role of the lymphatic system in drainage of cerebrospinal fluid and aqueous humour. J. Physiol. 299:353.
17. Wilbanks, G. A., and J. W. Streilein. 1989. The differing patterns of antigen release and local retention following anterior chamber and intravenous inoculation of soluble antigen: evidence that the eye acts as an antigen depot. Reg. Immunol. 2:390.
18. Egan, R. M., C. Yorkey, R. Black, W. K. Loh, J. L. Stevens, and J. G. Woodward. 1996. Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site. J. Immunol. 157:2262.
19. Perez, V. L., A. J. Biuckians, and J. W. Streilein. 2000. In-vivo impaired T helper 1 cell development in submandibular lymph nodes due to IL-12 deficiency following antigen injection into the anterior chamber of the eye. Ocul. Immunol. Inflamm. 8:9.
20. Tilney, N. L. 1971. Patterns of lymphatic drainage in the adult laboratory rat. J. Anat. 109:369.
21. Van Stipdonk, M. J., E. E. Lemmens, and S. P. Schoenberger. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immun. 2:423.
22. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immun. 2:415.
23. Plskova, J., L. Duncan, V. Holan, M. Filipec, G. Kraal, and J. V. Forrester. 2002. The immune response to comeal allograft requires a site-specific draining lymph node. Transplantation 73:210.
24. + T cells. J. Immunol. 169:5630.
25. Schurmans, L. R., A. T. den Boer, L. Diehl, E. I. van der Voort, W. M. Kast, C. J. Melief, R. E. Toes, and M. J. Jager. 1999. Successful immunotherapy of an intraocular tumor in mice. Cancer Res. 59:5250.
26. + tumors through induction of strong systemic cytotoxic T lymphocyte immunity. Proc. Natl. Acad. Sci. USA 99:5561.
27. Toes, R. E., R. Offringa, R. J. Blom, C. J. Melief, and W. M. Kast. 1996. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc. Natl. Acad. Sci. USA 93:7855.
28. Medema, J. P., J. de Jong, T. van Hall, C. J. Melief, and R. Offringa. 1999. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J. Exp. Med. 190:1033.
29. Franken, K. L., H. S. Hiemstra, K. E. van Meijgaarden, Y. Subronto, J. den Hartigh, T. H. Ottenhoff, and J. W. Drijfhout. 2000. Purification of histagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expression Purif. 18:95.
30. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131.
31. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
32. Katagiri, K., J. Zhang-Hoover, J. S. Mo, J. Stein-Streilein, and J. W. Streilein. 2002. Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology. J. Immunol. 169:84.
33. + T regulatory cells following antigen inoculation in an immune-privileged site. J. Immunol. 171:1266.
34. Tun, A. L., L. O'Brien, A. Hussain, G. R. Crowther, R. R. French, and M. J. Glennie. 2002. T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody. J. Immunol. 168:2720.
35. + T-helper and a T-killer cell. Nature 393:474.
36. + CTL responses in vivo. J. Immunol. 168:2240.
37. Gilliet, M., V. Soumelis, N. Watanabe, S. Hanabuchi, S. Antonenko, R. de Waal-Malefyt, and Y. J. Liu. 2003. Human dendritic cells activated by TSLP and CD40L induce proallergic cylotoxic T cells. J. Exp. Med. 197:1059.
38. Gong, H., R. C. Tripathi, and B. J. Tripathi. 1996. Morphology of the aqueous outflow pathway. Microsc. Res. Tech. 33:336.
39. Bill, A., and C. I. Phillips. 1971. Uveoscleral drainage of aqueous humour in human eyes. Exp. Eye Res. 12:275.
40. Tripathi, R. C. 1977. Uveoscleral drainage of aqueous humour. Exp. Eye Res. 25(Suppl. 1):305.
41. Streilein, J. W., and J. Y. Niederkorn. 1981. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J. Exp. Med. 153:1058.
42. Streilein, J. W., J. Y. Niederkorn, and J. A. Shadduck. 1980. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J. Exp. Med. 152:112.
43. Sonoda, K. H., M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein. 1999. CDI-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190:1215.
44. Faunce, D. E., K. H. Sonoda, and J. Slein-Streilein. 2001. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166:313.
45. Egan, R. M., C. Yorkey, R. Black, W. K. Loh, J. L. Stevens, E. Storozynsky, E. M. Lord, J. G. Frelinger, and J. G. Woodward. 2000. In vivo behavior of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T cell priming followed by anergy. J. Immunol. 164:4543.
46. + T cells after infection. Nat. Immun. 3:619.
47. + T cell tolerance. Immunity 18:713.
48. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213.
49. Jonuleit, H., E. Schmitt, K. Steinbrink, and A. H. Enk. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22:394.
50. + anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99:2468.